SA 1.3 What’s new in systemic treatment of patients with early breast cancer

SA 1.3 What’s new in systemic treatment of patients with early breast cancer

Bibliographic Details
Main Author:	K. Miller
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977623000711

Similar Items

SA 1.1 Surgery of patients with early breast cancer: Quo vadis?
by: W.P. Weber
Published: (2023-03-01)

SA 3.2 Tumor microenvironment in early breast cancer
by: C. Denkert
Published: (2023-03-01)

SA 1.4 Translational research priorities for patients with early breast cancer
by: F. André
Published: (2023-03-01)

SA 8.3 Emerging new treatments in HER2 positive breast cancer
by: M. Piccart
Published: (2023-03-01)

SA 5.3 What’s next? Antibody-drug conjugates for breast cancer therapy
by: L. Sanz, et al.
Published: (2023-03-01)

SA 1.2 Access to evidence based radiation therapy for patients with early breast cancer
by: P. Poortmans, M.D., Ph.D.
Published: (2023-03-01)

SA 6.1 Patient selection, dose and fractionation for external beam radiotherapy in patients with early breast cancer
by: C.E. Coles
Published: (2023-03-01)

SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer
by: H.S. Rugo
Published: (2023-03-01)

SA 9.3 Tackling triple negative histological subtypes in early breast cancer
by: J. Reis Filho
Published: (2023-03-01)

SA 10.3 Breast cancer treatment and research from an African perspective
by: H. Gamal-Eldin Mohamed Mahmoud
Published: (2023-03-01)

SA 11.4 Duration of endocrine therapy in early breast cancer
by: J. Huober
Published: (2023-03-01)

SA 10.1 Breast cancer treatment and research from a global perspective
by: B. Anderson
Published: (2023-03-01)

SA 4.2 Local treatment in patients with high risk hereditary breast cancer
by: M.-J. Cardoso
Published: (2023-03-01)

Early-stage cervical cancer treatment – what’s new?
by: Camilla Di Dio, et al.
Published: (2023-06-01)

SA 3.4 The future of breast cancer immunotherapy (PD, PDL, vaccines)
by: G. Curigliano
Published: (2023-03-01)

SA 2.2 Molecular Imaging in Breast Cancer
by: M. van Kruchten, et al.
Published: (2023-03-01)

AA 3 New drugs on the horizon for early breast cancer
by: M. Martin
Published: (2023-03-01)

Selecting chemotherapy schedules for adjuvant treatment of early stage breast cancer, what is the rationale behind?
by: Roham Salek, et al.
Published: (2015-07-01)

AA 3 Adequate treatment for early breast cancer in LMICs?
by: C. Barrios
Published: (2023-03-01)

SA 10.4 Breast cancer treatment and research from a Latin American perspective
by: D. Bretel
Published: (2023-03-01)

SA 6.3 Breast surgery after neoadjuvant therapy
by: A.V. Barrio
Published: (2023-03-01)

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
by: Elisa Agostinetto, et al.
Published: (2022-11-01)

The History of Early Breast Cancer Treatment
by: Judith Ben-Dror, et al.
Published: (2022-05-01)

What is the future in the treatment of triple-negative breast cancer?
by: Erdinc Nayir, MD
Published: (2017-12-01)

SaBrcada: Survival Intervals Prediction for Breast Cancer Patients by Dimension Raising and Age Stratification
by: Shih-Huan Lin, et al.
Published: (2023-07-01)

SaTransformer: Semantic‐aware transformer for breast cancer classification and segmentation
by: Jie Zhang, et al.
Published: (2023-11-01)

SA 4.1 Imaging, screening & surveillance for individuals with increased hereditary breast cancer risk
by: S. Delaloge
Published: (2023-03-01)

SURGICAL TRETMENT OF EARLY BREAST CANCER: WHAT HAS CHANGED? (EXPERIENCE OF INTERNATIONAL COOPERATION)
by: I. V. Kolyadina, et al.
Published: (2016-02-01)

Expression of CDK13 Was Associated with Prognosis and Expression of HIF-1α and beclin1 in Breast Cancer Patients
by: Xia-Liang Lu, et al.
Published: (2022-02-01)

Biological rationale for patient-specific treatment of breast cancer. Analysis of new data for breast cancer
by: R. M. Paltuev
Published: (2020-03-01)

SA 3.1 Understanding the anti-cancer immune response: Innate and adaptive responses to cancer cells
by: S. Loi
Published: (2023-03-01)

Gremlin-1 Promotes Metastasis of Breast Cancer Cells by Activating STAT3-MMP13 Signaling Pathway
by: Nam Ji Sung, et al.
Published: (2020-12-01)

The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.
by: Gray, R, et al.
Published: (1993)

Clinical Outcomes in Breast Cancer: Innovations and Ideas Commentary on “Expression of CDK13 was Associated with Clinical Outcomes and Expression of HIF-1 and Beclin1 in Breast Cancer Patients”
by: Giuseppe Diluiso, et al.
Published: (2022-02-01)

What's the buzz: Tell me what's happening in breast cancer screening
by: Sharon K Byrne
Published: (2017-01-01)

Hyperpolarized Carbon-13 MRI in Breast Cancer
by: Ramona Woitek, et al.
Published: (2023-07-01)

What are the clinicopathological features of elderly early-stage breast cancer patients and is there any difference in patients over 70 years of age?
by: Esin Oktay, et al.
Published: (2019-08-01)

Breast Cancer: Impact of New Treatments?
by: Guy A. Storme
Published: (2023-04-01)

CONSERVATIVE SURGERY IN THE COMPLEX TREATMENT FOR EARLY BREAST CANCER
by: M. S. Pirogova, et al.
Published: (2014-09-01)

The Adventure of Axillary Treatment in Early Stage Breast Cancer
by: Bekir Kuru
Published: (2020-01-01)